loading
Envista Holdings Corp stock is currently priced at $19.06, with a 24-hour trading volume of 3.00M. It has seen a +0.32% increased in the last 24 hours and a -6.84% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $19.43 pivot point. If it approaches the $18.53 support level, significant changes may occur.
Previous Close:
$19.00
Open:
$19.19
24h Volume:
3.00M
Market Cap:
$3.28B
Revenue:
$2.57B
Net Income/Loss:
$-100.20M
P/E Ratio:
17.65
EPS:
1.08
Net Cash Flow:
$217.50M
1W Performance:
-7.57%
1M Performance:
-6.84%
6M Performance:
-10.64%
1Y Performance:
-46.07%
1D Range:
Value
$18.89
$19.33
52W Range:
Value
$18.09
$36.14

Envista Holdings Corp Stock (NVST) Company Profile

Name
Name
Envista Holdings Corp
Name
Phone
714 817 7000
Name
Address
Building E, 200 South Kraemer Boulevard, Brea, CA
Name
Employee
12,500
Name
Twitter
Name
Next Earnings Date
2024-05-21
Name
Latest SEC Filings
Name
NVST's Discussions on Twitter

Envista Holdings Corp Stock (NVST) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-09-24 Downgrade Jefferies Buy → Hold
Feb-08-24 Downgrade William Blair Outperform → Mkt Perform
Jan-05-24 Initiated UBS Neutral
Dec-11-23 Downgrade Goldman Buy → Sell
Nov-16-23 Initiated Needham Hold
Nov-02-23 Downgrade Piper Sandler Overweight → Neutral
Aug-29-22 Upgrade Piper Sandler Neutral → Overweight
Jun-14-22 Downgrade Robert W. Baird Outperform → Neutral
Jan-31-22 Upgrade Morgan Stanley Equal-Weight → Overweight
Oct-26-21 Upgrade BofA Securities Neutral → Buy
Aug-05-21 Resumed Credit Suisse Outperform
Jan-08-21 Upgrade Credit Suisse Neutral → Outperform
Jun-16-20 Initiated Piper Sandler Neutral
Dec-17-19 Resumed Evercore ISI Outperform
Oct-14-19 Initiated BofA/Merrill Neutral
Oct-14-19 Initiated Credit Suisse Neutral
Oct-14-19 Initiated Evercore ISI Outperform
Oct-14-19 Initiated Goldman Buy
Oct-14-19 Initiated JP Morgan Overweight
Oct-14-19 Initiated Jefferies Buy
Oct-14-19 Initiated Morgan Stanley Equal-Weight
Oct-14-19 Initiated Robert W. Baird Outperform
Oct-14-19 Initiated Stifel Buy
Oct-14-19 Initiated William Blair Outperform
View All

Envista Holdings Corp Stock (NVST) Financials Data

Envista Holdings Corp (NVST) Revenue 2024

NVST reported a revenue (TTM) of $2.57 billion for the quarter ending December 31, 2023, a -0.10% decline year-over-year.
loading

Envista Holdings Corp (NVST) Net Income 2024

NVST net income (TTM) was -$100.20 million for the quarter ending December 31, 2023, a -141.22% decrease year-over-year.
loading

Envista Holdings Corp (NVST) Cash Flow 2024

NVST recorded a free cash flow (TTM) of $217.50 million for the quarter ending December 31, 2023, a +103.27% increase year-over-year.
loading

Envista Holdings Corp (NVST) Earnings per Share 2024

NVST earnings per share (TTM) was -$0.61 for the quarter ending December 31, 2023, a -144.53% decline year-over-year.
loading
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures and markets dental products in the United States and internationally. The company operates in two segment, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics, and dental eye loupes to oral surgeons, prosthodontists, and periodontists under the brands, including Nobel Biocare systems, Alpha Bio Tec, Implant Direct, Nobel Procera, and Orascoptic; and brackets and wires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Ormco, Insignia, AOA, and Spark brands. This segment also offers software packages used for the treatment planning of dental implants and prosthetics. The company's Equipment & Consumables segment develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; handpieces and associated consumables; treatment units and other dental practice equipment; endodontic systems and related consumables; and restorative materials and instruments, rotary burs, impression materials, bonding agents and cements, and infection prevention products. This segment offers its products under the Dexis, Gendex, i-CAT, KaVo, Pelton & Crane, Kerr, MetrexTM, Sybron Endo, Total Care, and Pentron brands to dental offices, clinics, and hospitals. The company was incorporated in 2018 and is headquartered in Brea, California.
medical_instruments_supplies TFX
$200.96
price down icon 1.01%
medical_instruments_supplies ATR
$149.04
price up icon 1.52%
$75.93
price down icon 0.80%
medical_instruments_supplies COO
$92.40
price up icon 1.94%
medical_instruments_supplies BAX
$36.51
price down icon 1.03%
medical_instruments_supplies WST
$366.54
price up icon 0.42%
Cap:     |  Volume (24h):